Caplin Point Laboratories Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Consolidate Annual Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Net Sales

2,187.19

1,937.47

1,694.10

1,466.73

1,269.41

1,061.29

863.20

Other Operating Income

0.00

Total Operating income

2,187.19

1,937.47

1,694.10

1,466.73

1,269.41

1,061.29

863.20

Raw Material Cost

357.20

297.32

267.10

206.28

192.31

129.82

108.12

Purchase of Finished goods

572.20

434.96

499.78

503.87

397.12

259.57

500.14

(Increase) / Decrease In Stocks

-63.72

38.56

-42.70

-46.94

-31.92

82.35

-195.10

Employee Cost

199.15

184.63

143.59

136.99

115.30

102.53

67.76

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

361.51

335.07

274.89

225.47

201.93

158.38

122.21

Total Expenditure (Excl Depreciation)

1,426.34

1,290.54

1,142.66

1,025.67

874.74

732.65

603.13

Operating Profit (PBDIT) excl Other Income

760.85

646.93

551.44

441.06

394.67

328.64

260.07

Other Income

115.54

96.43

66.94

55.98

38.75

23.54

41.33

Operating Profit (PBDIT)

876.39

743.36

618.38

497.04

433.42

352.18

301.40

Interest

0.87

0.61

0.78

0.70

1.59

0.32

Exceptional Items

0.00

Gross Profit (PBDT)

875.52

742.75

617.60

496.26

432.72

350.59

301.08

Depreciation

72.77

65.96

53.44

44.99

46.90

36.97

31.62

Profit Before Tax

802.75

676.79

564.16

451.27

385.82

313.62

269.46

Tax

153.06

135.69

103.01

74.36

77.37

62.18

54.38

Provisions and contingencies

0.00

Profit After Tax

649.69

541.10

461.15

376.91

308.45

251.44

215.08

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

649.69

541.10

461.15

376.91

308.45

251.44

215.08

Share in Profit of Associates

0.04

-0.01

0.27

0.08

0.00

Minority Interest

-8.49

-4.78

-4.33

-0.73

-8.61

-9.16

-0.08

Other related items

0.00

Consolidated Net Profit

641.24

536.31

457.09

376.26

299.84

242.28

215.00

Equity Capital

15.20

15.19

15.18

15.16

15.13

Face Value

2.0

Reserves

3,571.22

2,835.29

2,300.51

1,865.30

1,468.77

1,170.69

932.79

Earnings per share (EPS)

84.37

70.57

60.18

49.57

39.56

32.03

28.42

Diluted Earnings per share

84.11

70.25

59.9

49.18

39.26

31.71

28.2

Operating Profit Margin (Excl OI)

34.79%

33.39%

32.55%

30.07%

31.09%

30.97%

30.13%

Gross Profit Margin

40.03%

38.34%

36.46%

33.83%

34.09%

33.03%

34.88%

PAT Margin

29.71%

27.93%

27.24%

25.7%

24.3%

23.69%

24.92%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2026 is 12.89% vs 14.37% in Mar 2025

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 19.57% vs 17.33% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.61% vs 17.32% in Mar 2025

Interest

YoY Growth in year ended Mar 2026 is 42.62% vs -21.79% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Caplin Point Lab With

Select Peers

Figures in Cr

Consolidate Annual Results

Change(INR)

Change(%)

Net Sales

2,187.19

8,279.60

-6,092.41

-73.58%

Other Operating Income

0.00

Total Operating income

2,187.19

8,279.60

-6,092.41

-73.58%

Raw Material Cost

357.20

2,320.30

-1,963.10

-84.61%

Purchase of Finished goods

572.20

313.10

259.10

82.75%

(Increase) / Decrease In Stocks

-63.72

10.90

-74.62

-684.59%

Employee Cost

199.15

2,700.60

-2,501.45

-92.63%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

361.51

1,674.90

-1,313.39

-78.42%

Total Expenditure (Excl Depreciation)

1,426.34

7,019.80

-5,593.46

-79.68%

Operating Profit (PBDIT) excl Other Income

760.85

1,259.80

-498.95

-39.61%

Other Income

115.54

66.00

49.54

75.06%

Operating Profit (PBDIT)

876.39

1,325.80

-449.41

-33.90%

Interest

0.87

211.80

-210.93

-99.59%

Exceptional Items

0.00

-59.20

59.20

100.00%

Gross Profit (PBDT)

875.52

1,054.80

-179.28

-17.00%

Depreciation

72.77

440.40

-367.63

-83.48%

Profit Before Tax

802.75

614.40

188.35

30.66%

Tax

153.06

216.60

-63.54

-29.34%

Provisions and contingencies

0.00

Profit After Tax

649.69

397.80

251.89

63.32%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

649.69

397.80

251.89

63.32%

Share in Profit of Associates

0.04

-0.30

0.34

113.33%

Minority Interest

-8.49

1.00

-9.49

-949.00%

Other related items

0.00

Consolidated Net Profit

641.24

398.50

242.74

60.91%

Equity Capital

15.20

15.80

-0.60

-3.80%

Face Value

2.00

1.00

0.00

Reserves

3,571.22

7,077.00

-3,505.78

-49.54%

Earnings per share (EPS)

84.37

25.22

59.15

234.54%

Diluted Earnings per share

84.11

25.08

59.03

235.37%

Operating Profit Margin (Excl OI)

34.79%

15.32%

0.00

19.47%

Gross Profit Margin

40.03%

12.82%

0.00

27.21%

PAT Margin

29.71%

4.83%

0.00

24.88%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 2,187.19 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 12.89% vs 14.37% in Mar 2025

Annual - Consolidate Net Profit

Consolidate Net Profit 641.24 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 19.57% vs 17.33% in Mar 2025

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 760.85 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 17.61% vs 17.32% in Mar 2025

Annual - Interest

Interest 0.87 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 42.62% vs -21.79% in Mar 2025

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 34.79%

in Mar 2026

Figures in %

YoY Growth in year ended Mar 2026 has improved from Mar 2025